Home › Funds › Citigroup Inc › RPRX
Citigroup Inc position in RPRX
ROYALTY PHARMA PLC · Health Care
Latest position (Q2 2026)496.40K sh
Reported value held$27.83M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 130.56K | $4.72M | New |
| Q4 2021 | 116.89K | $4.66M | Reduce |
| Q1 2022 | 153.95K | $6.00M | Add |
| Q2 2022 | 114.39K | $4.81M | Reduce |
| Q3 2022 | 123.28K | $4.95M | Add |
| Q4 2022 | 102.80K | $4.06M | Reduce |
| Q1 2023 | 171.94K | $6.20M | Add |
| Q2 2023 | 246.57K | $7.58M | Add |
| Q3 2023 | 279.15K | $7.58M | Add |
| Q4 2023 | 327.99K | $9.21M | Add |
| Q1 2024 | 471.84K | $14.33M | Add |
| Q2 2024 | 594.74K | $15.68M | Add |
| Q3 2024 | 528.50K | $14.95M | Reduce |
| Q4 2024 | 357.04K | $9.11M | Reduce |
| Q1 2025 | 333.89K | $10.39M | Reduce |
| Q2 2025 | 386.30K | $13.92M | Add |
| Q3 2025 | 253.45K | $8.94M | Reduce |
| Q4 2025 | 364.23K | $14.07M | Add |
| Q1 2026 | 460.43K | $22.09M | Add |
| Q2 2026 | 496.40K | $27.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RPRX
- Morgan Stanley 42.93M sh · $2.41B · Q2 2026
- BlackRock Inc 27.83M sh · $1.56B · Q2 2026
- Fidelity Management & Research (FMR) 24.51M sh · $1.37B · Q2 2026
- Baillie Gifford & Co 10.02M sh · $561.57M · Q2 2026
- Capital World Investors 9.52M sh · $533.64M · Q2 2026
- Geode Capital Management 8.06M sh · $450.58M · Q2 2026
- Vanguard Group 9.93M sh · $383.87M · Q4 2025
- Norges Bank Investment Management 5.34M sh · $299.19M · Q2 2026
- Northern Trust Corp 4.72M sh · $264.59M · Q2 2026
- AQR Capital Management 4.31M sh · $241.40M · Q2 2026
- Invesco Ltd 4.23M sh · $237.32M · Q2 2026
- Bank of America Corp 4.15M sh · $232.66M · Q2 2026